Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

VAPRED Study

Introduction

Official Title

Official Title

Study of Predictive Echo Doppler Score and D-dimer Level in Evaluation of the Thromboembolic Event Recurrence After Anticoagulant Treatment Cessation

Objective

Objective

The purpose of this trial is to perform a prospective multicentric study to determine predictive ED score and D-dimer level in the evaluation of the thromboembolic event recurrence after anticoagulant treatment cessation

Sponsor

University Hospital, Grenoble

Timeline

Timeline

Timeline
Start Date March 2005
End Date May 2010
Status phase 4

The previous information was derived from ClinicalTrials.gov on 09/25/2013 using the identification number NCT00860106 .

Study Description

Study Description

Study Description
Study Type Interventional
Study Phase Phase 4
Study Design
Allocation Non-Randomized
Endpoint Safety Study
Interventional Model Single Group Assignment
Masking Open Label
Study Details
Primary Purpose Prevention
Condition Previous Vka Treatment
Previous Proximal VTE
Intervention Echo Doppler (ED), DDimers and phone follow up
ED score, DDimers level and phone questionnary
Study Arms Follow up
ED score and DDimer level of patients who have stopped their VKA treatment (after the first or the second previous proximal VTE).
Phone follow up for 2 years.
Intervention: Other: ED, DDimers and phone follow up
Population Size 222

The previous information was derived from ClinicalTrials.gov on 09/25/2013 using the identification number NCT00860106 .

Eligibility Criteria

Eligibility Criteria

Inclusion Criteria

  • >18 and <80 years old
  • First or second treated proximal VTE event (+/- Pulmonary embolism)
  • Signed informed consent

Exclusion Criteria

  • Active cancer or currently treated
  • Previous VTE>2
  • Long term anticoagulant treatment for VTE diseases
  • Long term anticoagulant treatment for other diseases
  • Pregnancy, parturient or breast feeding
  • Person deprived of freedom by judicial or administrative decision
  • Consent unsigned
Outcomes

Outcomes

Primary Outcomes

VTE event recurrence [ Time Frame: 0-2 years ] [ Designated as safety issue: Yes ]

Secondary Outcomes

Not provided

Publications

Publications

Results

Conclusion

References

References

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]